654 related articles for article (PubMed ID: 6172710)
1. Concurrent sickle-cell anemia and alpha-thalassemia: effect on severity of anemia.
Embury SH; Dozy AM; Miller J; Davis JR; Kleman KM; Preisler H; Vichinsky E; Lande WN; Lubin BH; Kan YW; Mentzer WC
N Engl J Med; 1982 Feb; 306(5):270-4. PubMed ID: 6172710
[TBL] [Abstract][Full Text] [Related]
2. The interaction of alpha-thalassemia and homozygous sickle-cell disease.
Higgs DR; Aldridge BE; Lamb J; Clegg JB; Weatherall DJ; Hayes RJ; Grandison Y; Lowrie Y; Mason KP; Serjeant BE; Serjeant GR
N Engl J Med; 1982 Jun; 306(24):1441-6. PubMed ID: 6176865
[TBL] [Abstract][Full Text] [Related]
3. Alpha thalassemia changes erythrocyte heterogeneity in sickle cell disease.
Noguchi CT; Dover GJ; Rodgers GP; Serjeant GR; Antonarakis SE; Anagnou NP; Higgs DR; Weatherall DJ; Schechter AN
J Clin Invest; 1985 May; 75(5):1632-7. PubMed ID: 2581999
[TBL] [Abstract][Full Text] [Related]
4. A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders.
Perrine SP; Ginder GD; Faller DV; Dover GH; Ikuta T; Witkowska HE; Cai SP; Vichinsky EP; Olivieri NF
N Engl J Med; 1993 Jan; 328(2):81-6. PubMed ID: 7677966
[TBL] [Abstract][Full Text] [Related]
5. Concurrent sickle cell anemia and alpha-thalassemia. Effect on pathological properties of sickle erythrocytes.
Embury SH; Clark MR; Monroy G; Mohandas N
J Clin Invest; 1984 Jan; 73(1):116-23. PubMed ID: 6690472
[TBL] [Abstract][Full Text] [Related]
6. The effect of Hb F and alpha-thalassemia on the red cell indices in sickle cell anemia.
Milner PF; Garbutt GJ; Nolan-Davis LV; Jonah F; Wilson LB; Wilson JT
Am J Hematol; 1986 Apr; 21(4):383-95. PubMed ID: 2420172
[TBL] [Abstract][Full Text] [Related]
7. Hematologically and genetically distinct forms of sickle cell anemia in Africa. The Senegal type and the Benin type.
Nagel RL; Fabry ME; Pagnier J; Zohoun I; Wajcman H; Baudin V; Labie D
N Engl J Med; 1985 Apr; 312(14):880-4. PubMed ID: 2579336
[TBL] [Abstract][Full Text] [Related]
8. Effects of alpha-thalassemia-2 on the developmental changes of hematological values in children with sickle cell disease from Georgia.
Felice AE; McKie KM; Cleek MP; Marino EM; Kutlar A; McKie VC
Am J Hematol; 1987 Aug; 25(4):389-400. PubMed ID: 2441597
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of sickle cell disease as shown by density profiles: effects of fetal hemoglobin and alpha thalassemia.
Baudin V; Pagnier J; Labie D; Girot R; Wajcman H
Haematologia (Budap); 1986; 19(3):177-84. PubMed ID: 2430866
[TBL] [Abstract][Full Text] [Related]
10. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease.
Rodgers GP; Dover GJ; Uyesaka N; Noguchi CT; Schechter AN; Nienhuis AW
N Engl J Med; 1993 Jan; 328(2):73-80. PubMed ID: 7677965
[TBL] [Abstract][Full Text] [Related]
11. Lack of influence of fetal hemoglobin levels or erythrocyte indices on the severity of sickle cell anemia.
Powars DR; Schroeder WA; Weiss JN; Chan LS; Azen SP
J Clin Invest; 1980 Mar; 65(3):732-40. PubMed ID: 6153392
[TBL] [Abstract][Full Text] [Related]
12. Pain in sickle cell disease. Rates and risk factors.
Platt OS; Thorington BD; Brambilla DJ; Milner PF; Rosse WF; Vichinsky E; Kinney TR
N Engl J Med; 1991 Jul; 325(1):11-6. PubMed ID: 1710777
[TBL] [Abstract][Full Text] [Related]
13. Foetal haemoglobin levels in sickle cell anaemia in Nigerians.
Falusi AG; Esan GJ
Afr J Med Med Sci; 1989 Jun; 18(2):145-9. PubMed ID: 2474239
[TBL] [Abstract][Full Text] [Related]
14. Modification of hemoglobin H disease by sickle trait.
Matthay KK; Mentzer WC; Dozy AM; Kan YW; Bainton DF
J Clin Invest; 1979 Oct; 64(4):1024-32. PubMed ID: 479366
[TBL] [Abstract][Full Text] [Related]
15. Effect of alpha-thalassemia and beta-globin gene cluster haplotypes on the hematological and clinical features of sickle-cell anemia in Brazil.
Figueiredo MS; Kerbauy J; Gonçalves MS; Arruda VR; Saad ST; Sonati MF; Stoming T; Costa FF
Am J Hematol; 1996 Oct; 53(2):72-6. PubMed ID: 8892730
[TBL] [Abstract][Full Text] [Related]
16. What determines severity in sickle-cell disease?
Schechter AN; Bunn HF
N Engl J Med; 1982 Feb; 306(5):295-7. PubMed ID: 6172711
[No Abstract] [Full Text] [Related]
17. Sickle cell syndromes. I. Hemoglobin SC-alpha-thalassemia.
Honig GR; Gunay U; Mason RG; Vida LN; Ferenc C
Pediatr Res; 1976 Jun; 10(6):613-20. PubMed ID: 1272638
[TBL] [Abstract][Full Text] [Related]
18. alpha-Thalassemia and HbF concentration in sickle cell anemia.
Rucknagel D; Ferrucci S; Whitten CF; Sarniak I; Odenheimer D; Sing C; Bruzdzinski C
Prog Clin Biol Res; 1984; 165():103-20. PubMed ID: 6209727
[No Abstract] [Full Text] [Related]
19. Extended therapy with intravenous arginine butyrate in patients with beta-hemoglobinopathies.
Sher GD; Ginder GD; Little J; Yang S; Dover GJ; Olivieri NF
N Engl J Med; 1995 Jun; 332(24):1606-10. PubMed ID: 7753139
[TBL] [Abstract][Full Text] [Related]
20. The cellular basis for different fetal hemoglobin levels among sickle cell individuals with two, three, and four alpha-globin genes.
Dover GJ; Chang VT; Boyer SH; Serjeant GR; Antonarakis S; Higgs DR
Blood; 1987 Jan; 69(1):341-4. PubMed ID: 2431731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]